Home » Topics » Regulatory » Patents

Patents
RSS

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

Eisai claims prostaglandin/leukotriene production inhibitors for pain and inflammation

July 5, 1996

Searle claims NOS inhibitors

July 5, 1996

BMS describes antifungal effects of ascosteroside

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

5-HT4 agonists in Nisshin Flour Milling's pipeline

June 28, 1996

Human Genome Sciences discloses polypeptide research

June 28, 1996

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...